Tech Company Financing Transactions
KOA Biotech Funding Round
KOA Biotech, based in Barcelona, secured $2.1 million in funding from Swanlaab Venture Factory and Faber Ventures.
Transaction Overview
Company Name
Announced On
2/6/2025
Transaction Type
Venture Equity
Amount
$2,100,000
Round
Undisclosed
Investors
Swanlaab Venture Factory (Lead Investor) (Nora Alonso)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Dr Aiguader 88
Barcelona, 08003
Spain
Barcelona, 08003
Spain
Phone
Website
Email Address
Overview
We provide a digital, autonomous and on-site testing technology for fish farms to reduce fish mortality. Our technology will revolutionize fish health and fish farm economics, and reduce their environmental impact worldwide. Over 50% of the fish we consume today comes from farms. Today's testing technology consists of water samples shipped to labs that take 5 to 10 days to deliver results. Our onsite testing kits continually monitor potentially harmful bacteria in water and create early warning alerts to prevent infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sira Mogas
Chief Technical Officer
Jordi Jubany
Browse more venture capital transactions:
Prev: 2/5/2025: Astra Security venture capital transaction
Next: 2/6/2025: COEPTIS venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs